YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
SEVENUM, THE NETHERLANDS - September 28, 2026 (NEWMEDIAWIRE) - Today, Redcare Pharmacy N.V. announced that it is raising its full-year 2026 guidance for the second time this year. The upgrade is driven by continued strong momentum in Rx re…
Investing.com -- Jefferies sees improving prospects across European midcaps heading into the second half of 2026, pointing to stronger order intake, improving momentum and greater earnings visibility after a broadly positive second-quarter…
This article first appeared on GuruFocus. Release Date: July 29, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Redcare Pharmacy NV (SHPPF) increased its 2026 reven…
As European markets experience an upswing, driven by optimism around geopolitical developments and positive index performances, investors are increasingly seeking robust growth opportunities. In this context, companies with strong insider…
As European markets face a downturn, with the pan-European STOXX Europe 600 Index ending the week down 2.54% amid geopolitical tensions and economic uncertainties, investors are increasingly looking towards growth companies with significan…
We feel now is a pretty good time to analyse Redcare Pharmacy NV's (ETR:RDC) business as it appears the company may be on the cusp of a considerable accomplishment. Redcare Pharmacy NV operates the online pharmacy business in the Netherlan…
As the European markets show resilience with the STOXX Europe 600 Index rising by 0.77%, investors are keenly observing growth opportunities amid mixed performances across major indices. In this environment, companies with strong insider o…
Key Insights Redcare Pharmacy's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 11 investors have a majority stake in the company with 51% ownership 14…
As the European market navigates a mixed landscape with slight fluctuations in major indices and potential policy shifts by the European Central Bank, investors are keenly observing growth opportunities within the region. In this context,…
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Redcare Pharmacy NV's (ETR:RDC) case, it's fantastic news for shareholders. While we would never suggest that inves…
As European markets navigate the relief of the U.S. federal government reopening, tempered by cooling sentiment around artificial intelligence, investors are keenly observing growth stocks with high insider ownership as potential opportuni…
SEVENUM, The Netherlands - November 10, 2025 (NEWMEDIAWIRE) - Redcare Pharmacy's Supervisory Board has designated Hendrik Krampe as member of the Managing Board and Chief Financial Officer, effective 1 December 2025. He succeeds Jasper Een…
It's been a mediocre week for Redcare Pharmacy NV (ETR:RDC) shareholders, with the stock dropping 12% to €71.05 in the week since its latest third-quarter results. It was an okay result overall, with revenues coming in at €719m, roughly wh…
In a mixed week for European markets, the pan-European STOXX Europe 600 Index edged higher amid dovish signals from the U.S. Federal Reserve and easing trade tensions between the U.S. and China, while major indexes such as Germany’s DAX an…
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But in contrast you can make much more than 100% if the company does well. For instance the Redcare Pharmacy NV (ETR:…
Total sales up 25% to EUR 719M in Q3. YTD total sales up 27% or EUR 450M to EUR 2.15bn. Non-Rx sales up 17% to EUR 448M in Q3; YTD 18% to EUR 1.4bn. Rx sales in Germany up 82% to EUR 126M in Q3, YTD 122% and EUR 348M. Number of active cust…
As the European markets navigate a landscape of mixed performances and monetary policy decisions, investors are keenly assessing growth opportunities amid these shifting economic conditions. In this environment, companies with high insider…
As European markets experience a positive shift, with the pan-European STOXX Europe 600 Index rising by 1.40% amid hopes for lower U.S. borrowing costs, investors are keenly watching growth stocks that promise robust returns. In this envir…
Redcare Pharmacy NV (ETR:RDC) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, B…
Redcare Pharmacy (ETR:RDC) Second Quarter 2025 Results Key Financial Results Revenue: €709.2m (up 27% from 2Q 2024). Net income: €9.35m (up from €4.27m loss in 2Q 2024). Profit margin: 1.3% (up from net loss in 2Q 2024). The move to profit…
As the European market navigates a landscape of mixed stock index performances and ongoing trade discussions with the U.S., investors are increasingly attentive to companies that demonstrate robust growth potential. In this context, stocks…
Key Insights The considerable ownership by individual investors in Redcare Pharmacy indicates that they collectively have a greater say in management and business strategy A total of 13 investors have a majority stake in the company with 5…
As the European market navigates through geopolitical tensions and economic uncertainties, reflected by the recent declines in major indices like the STOXX Europe 600, investors are increasingly seeking stability and growth potential. In t…
The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index ending a five-week streak of gains due to renewed tariff threats from the U.S., and economic growth forecasts being revised downwards by the Eu…
As trade tensions between the U.S. and China show signs of easing, European markets have responded positively, with major indices like Germany's DAX and France's CAC 40 seeing notable gains. Against this backdrop of cautious optimism, inve…
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Redcare Pharmacy NV (ETR:RDC)…
As European markets show signs of recovery, with the STOXX Europe 600 Index snapping a two-week losing streak, investors are keeping a close watch on growth stocks that insiders are heavily investing in. In an environment where government…
Investors in Redcare Pharmacy NV (ETR:RDC) had a good week, as its shares rose 2.9% to close at €127 following the release of its yearly results. Revenues came in at €2.4b, in line with expectations, while statutory losses per share were s…
As European markets navigate a landscape marked by U.S. trade policy uncertainties and recent ECB rate cuts, investor sentiment has been mixed, with the STOXX Europe 600 Index snapping a ten-week streak of gains. Amid these conditions, ide…
Redcare Pharmacy (ETR:RDC) Full Year 2024 Results Key Financial Results Revenue: €2.37b (up 32% from FY 2023). Net loss: €45.5m (loss widened by 278% from FY 2023). €2.27 loss per share (further deteriorated from €0.63 loss in FY 2023).XTR…
Amidst cautious optimism in Europe, the pan-European STOXX Europe 600 Index has shown slight gains as investors navigate U.S. trade policy developments and efforts to resolve the Russia-Ukraine conflict. In this environment, growth compani…
With the business potentially at an important milestone, we thought we'd take a closer look at Redcare Pharmacy NV's (ETR:RDC) future prospects. Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, B…
Potential Redcare Pharmacy NV (ETR:RDC) shareholders may wish to note that the Independent Deputy Chairman of Supervisory Board, Frank Kohler, recently bought €238k worth of stock, paying €119 for each share. That's a very decent purchase…
As global markets show signs of recovery with cooling inflation and strong bank earnings propelling U.S. stocks higher, investors are increasingly attentive to growth companies that demonstrate resilience in such fluctuating conditions. A…
Key Insights Redcare Pharmacy's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 12 investors have a majority stake in the company with 51% ownership 17…
Amidst a backdrop of easing monetary policy in Europe, Germany's DAX has shown positive momentum, reflecting investor optimism following the European Central Bank's recent rate cuts. In this environment, growth companies with substantial i…